| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/12/2007 | WO2007060419A3 Method of preventing oral staining |
| 07/12/2007 | WO2007056618A9 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 07/12/2007 | WO2007047577A3 Use of calcitonin-related peptide (cgrp) antagonists or release inhibitors for the treatment of sleep-related breathing disorders |
| 07/12/2007 | WO2007041410A3 Sustained release small molecule drug formulation |
| 07/12/2007 | WO2007029063A3 Treatment and/or prevention of pervasive developmental disorders |
| 07/12/2007 | WO2007019888A3 Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases |
| 07/12/2007 | WO2007014033A3 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
| 07/12/2007 | WO2006025995A3 Compositions and methods using md-2 mutants and chimeric proteins |
| 07/12/2007 | WO2005048925A3 Methods for treating a neoplastic disease in a subject using inorganic selenium-containing compounds |
| 07/12/2007 | US20070161708 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 07/12/2007 | US20070161707 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161706 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161704 Pharmaceutical composition useful for treating chronic myeloid leukemia |
| 07/12/2007 | US20070161699 Method of preventing or treating glaucoma |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161665 Cancer treatment method |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161631 Substituted Phenoxyacetic Acids |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161604 urinary diseases, central nervous diseases, inflammatory diseases, circulatory diseases, cancer, diabetes, immune system disorders and alimentary diseases |
| 07/12/2007 | US20070161584 gene therapy of transferring the CD9 gene for suppressing cardiac hypertrophy or cardiac tachycardia in a patient having a heart disease; viral or non-viral expression vector containing a sequence encoding a CD9 protein |
| 07/12/2007 | US20070161560 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/12/2007 | US20070161540 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
| 07/12/2007 | US20070161080 Antibodies |
| 07/12/2007 | US20070161063 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/12/2007 | US20070161046 Truncated aggrecanase molecules |
| 07/12/2007 | US20070161021 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 07/12/2007 | US20070160700 Methods and compositions for reactivating acetylcholinesterase |
| 07/12/2007 | US20070160697 Cancer metastasis inhibitory composition |
| 07/12/2007 | US20070160690 Composition and method to augment and sustain neurotransmitter production |
| 07/12/2007 | US20070160685 Methods for treating a neoplastic disease in a subject using inorganic selenium-containing compounds |
| 07/12/2007 | US20070160666 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; free of ascorbic acid and pregelatinized starch; for treatment of atheroslerosis; stability |
| 07/12/2007 | US20070160665 Chlorthalidone combinations |
| 07/12/2007 | US20070160650 Stimulating nitric oxide production and white blood cell production for antiviral activity; oral administration of neurotransmitter precursors, along with natural plant extracts that stimulate uptake of the neurotransmitters precursors, and other plant substances for side effect reduction |
| 07/12/2007 | US20070160608 Treatment with anti-vegf antibodies |
| 07/12/2007 | US20070160590 Metabolic uncoupling therapy |
| 07/12/2007 | US20070160567 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 07/12/2007 | US20070160545 Method for reducing ultraviolet light induced apoptosis |
| 07/12/2007 | US20070160539 HPRP4s Modifiers of the p53 Pathway and Methods of Use |
| 07/12/2007 | US20070160537 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| 07/12/2007 | DE10045904B4 alpha-Liponsäure(-Derivate) enthaltende Retardform alpha-lipoic acid (derivatives) containing sustained release form |
| 07/12/2007 | CA2635994A1 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 07/12/2007 | CA2635992A1 Medicament for topical use |
| 07/12/2007 | CA2635986A1 Composition and method of use thereof |
| 07/12/2007 | CA2635649A1 New pharmaceutical compositions based on anticholinergics and andolast |
| 07/11/2007 | EP1806404A1 Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/11/2007 | EP1806367A2 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/11/2007 | EP1806364A2 New anti-IGF-IR antibodies and their applications |
| 07/11/2007 | EP1806353A1 Antisense modulation of novel anti-apoptotic BCL-2-related proteins |
| 07/11/2007 | EP1806152A1 Drug for external use and adhesive patch |
| 07/11/2007 | EP1806151A1 Drug for external use and adhesive patch |
| 07/11/2007 | EP1806149A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 07/11/2007 | EP1806148A1 Medicinal composition for inhalation |
| 07/11/2007 | EP1806147A1 Use of immunesuppressant receptor |
| 07/11/2007 | EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines |
| 07/11/2007 | EP1806145A1 Remedy for inflammatory diseases |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1806138A1 Anti-tumor agents comprising boroproline compounds |
| 07/11/2007 | EP1806135A2 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| 07/11/2007 | EP1806131A2 Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| 07/11/2007 | EP1804837A2 Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor |
| 07/11/2007 | EP1804819A2 Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus |
| 07/11/2007 | EP1804787A2 Flavonoid composition for treating oral diseases |
| 07/11/2007 | EP1804783A1 Method of using adapalene in acne maintenance therapy |
| 07/11/2007 | EP1741425A4 Novel antiviral pharmaceutical composition |
| 07/11/2007 | EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/11/2007 | EP1551395B1 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist |
| 07/11/2007 | EP1530471B1 Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1458398A4 Antibiotic formulation and a method of making this formulation |
| 07/11/2007 | EP1303265B1 Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids |
| 07/11/2007 | EP1237925B1 Mutant er-alpha and test systems for transactivation |
| 07/11/2007 | EP1177445B1 Methods for screening gaba-modulatory compounds for specified pharmacological activities |
| 07/11/2007 | EP1154788B1 Inhibitors of separin, method for identifying them and uses |
| 07/11/2007 | EP1135128B1 Novel method of treatment |
| 07/11/2007 | EP0998291B1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/11/2007 | CN1997396A Combination therapy of AZD2171 and taxane |
| 07/11/2007 | CN1997395A Drug having regulatory cell ligand contained in liposome |
| 07/11/2007 | CN1997366A Imidazole and thiazole derivatives as antiviral agents |
| 07/11/2007 | CN1997364A Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds |
| 07/11/2007 | CN1997361A Antitumor agent |
| 07/11/2007 | CN1997353A Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy |
| 07/11/2007 | CN1997347A Personal care compositions and methods regulating mammalian hair growth and skin condition |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1994468A Unfavorable taste-masking drug granule, chewable formulation and preparation process thereof |
| 07/11/2007 | CN1994466A Use of composition for treatment of viral infections |
| 07/11/2007 | CN1994287A 抗癌组合 Anticancer combination |
| 07/11/2007 | CN1325645C Histamine and serotonin binding molecules |
| 07/11/2007 | CN1325643C Oligonucleotides modulating expression of enzymes involved in synthesis of melanic pigments |
| 07/11/2007 | CN1325498C Novel crystalline compound |
| 07/11/2007 | CN1325118C Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 07/11/2007 | CN1325050C Pharmaceutical composition comprising a lipase inhibitor and glucomannan |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241860 Transcription factor polypeptide that regulates Chondromodulin-I expression |
| 07/10/2007 | US7241796 Peptidomimetic compounds |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241762 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 07/10/2007 | US7241756 Containing 5-[4-[2[(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a salt for treating non-insulin dependent diabetes with improved blood glucose regulation without introducing unacceptable side-effects |
| 07/10/2007 | US7241753 Method of treatment of prostate cancer |